Observe
Identify clinically meaningful features in imaging and pathology.
AI and multimodal intelligence for oncology
Revealing clinically meaningful signals hidden in cancer data.
Existential Intelligence combines radiological imaging, digital pathology, machine learning, and specialized clinical expertise to develop prognostic insights for clinical trials, drug development, diagnostics, and patient care.
Radiology
Pathology
Clinical data
Separate modalities. One clinically meaningful picture.
Our thesis
Cancer data is often analyzed in fragments. Its greatest value may exist in the relationships between them.
Radiology, pathology, biomarkers, and clinical outcomes are commonly evaluated through separate workflows. Existential Intelligence develops models and analytical methods that connect these sources to identify patterns associated with disease progression, treatment response, prognosis, and clinical-trial outcomes.
Connect
Relate those features to biological, treatment, and outcome data.
Translate
Develop validated insights, partner programs, and commercial products.
Prognostic signal
Our scientific advantage
Specialized clinical knowledge is the foundation of useful oncology AI.
Our initial focus is macrovascular invasion in pancreatic ductal adenocarcinoma and other cancers with high vascular proximity. This work brings together expertise in radiology, pathology, oncology, biomedical informatics, machine learning, and secure software development.
A clinically important beachhead
Macrovascular invasion may influence prognosis, treatment response, patient stratification, and the interpretation of clinical-trial outcomes.
A multidisciplinary expert network
Our coalition includes specialists with access to clinical collaborators, patient populations, imaging, pathology, and pancreatic cancer expertise across multiple institutions and regions.
A platform built to expand
The same combination of scientific expertise, multimodal data, and computational methods can support additional cancer indications, biomarkers, and commercial applications.
PhaseVantage applies this expertise to clinical-development decisions in pancreatic cancer. Visit PhaseVantage →
Commercial roadmap
One scientific platform. Multiple paths to commercial value.
Existential Intelligence is developing a portfolio of opportunities around imaging-derived biomarkers, digital pathology, prognostic modeling, clinical-development intelligence, and longitudinal treatment assessment.
1. Validate specialized insights
Retrospective studies, cohort analysis, model development, and external validation.
2. Develop with strategic partners
Milestone-based programs with pharmaceutical, diagnostic, clinical, and data partners.
3. Translate into commercial offerings
Clinical-trial services, licensed models, diagnostic products, decision-support tools, royalties, and product-specific revenue sharing.
Clinical-trial intelligenceImaging-derived biomarkersH&E digital pathologyPrognostic modelsTreatment-effect assessmentAdditional cancer indications
Strategic partnerships
Combine specialized oncology intelligence with the infrastructure required to validate, scale, and commercialize it.
What We Bring
- Specialized expertise in macrovascular invasion and cancers with high vascular proximity
- Multimodal imaging, pathology, and clinical-data capabilities
- An international coalition of clinical and scientific collaborators
- Proprietary methods, models, workflows, and technical expertise
- A team spanning clinical science, AI, informatics, and secure software engineering
Where Partners Add Value
- Clinical datasets and specimens
- External validation sites
- Diagnostic infrastructure
- Regulatory and reimbursement expertise
- Pharmaceutical development programs
- Commercial distribution and market access
- Strategic investment
Engagements may include strategic investment, sponsored development, validation programs, licensing, clinical-trial services, and product-specific commercialization.
Insights
Scientific and commercial perspectives
Start a conversation